Tumor necrosis factor α antibody (infliximab) therapy profoundly down- regulates the inflammation in Crohn's ileocolitis

Gastroenterology

Volumn 116, Issue 1, 1999, Pages 22-28

  Baert, F J ^a   D'Haens, G R ^a   Peeters, M ^a   Hiele, M I ^a   Schaible, T F ^a   Shealy, D ^a   Geboes, K ^a   Rutgeerts, P J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; INFLIXIMAB; MESALAZINE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLITIS; COLON BIOPSY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DOUBLE BLIND PROCEDURE; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; ILEITIS; INFLAMMATION; INFLAMMATORY DISEASE; INTESTINE BIOPSY; INTESTINE MUCOSA; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032923705     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(99)70224-6     Document Type: Article

References (24)

1. B. Beutler The role of tumor necrosis factor 1992 : Raven New York
2. JA Barbara X Van Ostade A. Lopez Tumor necrosis factor alpha (TNF-α): the good, the bad and the potentially very effective Immunol Cell Biol 75 1996 434 443
3. NH. Riddle Tumor necrosis factor (TNF-α) and lymphotoxin (TNF-β) Curr Opin Immunol 4 1992 327 332
4. SE Plevy SR Targan RL Deem H. Toyoda Increased mucosal TNF-α levels and numbers of TNF-α producing cells are unique to Crohn's disease mucosal inflammation (abstr) Gastroenterology 106 1995 A754
5. EJ Breese CA Michie SW Nicholls SH Murch CB Williams P Domizio JA Walker-Smith TT. McDonald Tumor necrosis factor α–producing cells in the intestinal mucosa of children with inflammatory bowel disease Gastroenterology 106 1994 1455 1466
6. CP Braegger S Nicholls SH Murch S Stephens TT. MacDonald Tumor necrosis factor alpha in stool as a marker of intestinal inflammation Lancet 339 1992 89 91
7. SH Murch CP Braegger JA Walker-Smith TT. MacDonald Location of tumor necrosis factor α by immunohistochemistry in chronic inflammatory bowel disease Gut 34 1993 1705 1709
8. NW Lukacs SW Chensue R Strieter K Warmington SL. Kunkel Inflammatory granuloma formation is mediated by TNF-alpha inducible intercellular adhesion molecule-1 J Immunol 152 1994 5883 5889
9. DM Knight H Trinh J Le S Siegel D Shealy M McDonough B Scallon M Arevalo Moore J Vilcek P Daddona J. Ghrayeb Construction and initial characterization of a mouse-human anti-TNF-antibody Mol Immunol 30 1993 1443 1453
10. SA Siegel DJ Shealy MT Nakada J Le DS Woulfe L Probert G Kollias J Ghrayeb J Vilcek PE. Dadonna The mouse/human chimeric monoclonal antibody cA2 neutralizes in vitro and protects transgenic mice from cachexia and TNF-α lethality in vivo Cytokine 7 1995 15 25
11. BJ Scallon MA Moore H Trinh DM Knight J. Ghrayeb Chimeric anti–TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions Cytokine 7 1995 251 259
12. SR Targan SB Hanauer SJH van Deventer L Mayer DH Present T Braakman KL DeWoody TF Schaible PJ. Rutgeerts A short term study of chimeric monoclonal antibody (cA2) to tumor necrosis factor α for Crohn's disease N Engl J Med 337 1997 1029 1035
13. P Rutgeerts G D'Haens SJH van Deventer DH Present L Mayer SB Hanauer TAJ Braakman KL DeWoody TF Schaible SR. Targan Retreatment with anti-TNF-α chimeric antibody effectively maintains cA2-induced remission in Crohn's disease (abstr) Gastroenterology 112 1997 A1078
14. HM van Dullemen SJH van Deventer DW Hommes HA Bijl J Jansen GNJ Tytgat J. Woody Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2) Gastroenterology 109 1995 129 135
15. WR Best JM Bektel JW Singleton F. Kern Development of a Crohn's disease activity index Gastroenterology 70 1976 439 444
16. GR D'Haens K Geboes M Peeters F Baert F Penninckx P. Rutgeerts Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum Gastroenterology 114 1998 262 267
17. SA Radema A Stronkhorst H Bijl GNJ Tytgat SJH. van Deventer Anti-CD 4 therapy decreases epithelial expression of HLA-DR molecules in patients with Crohn's disease IBD 1 1995 193 197
18. PP Tak PC Taylor FC Breedveld TJM Smeets MR Daha PM Kluin AE Meinders RN. Maini Decrease in cellularity and expression of adhesion molecules by anti–tumor necrosis factor α: a monoclonal antibody treatment in patients with rheumatoid arthritis Arthritis Rheum 39 1996 1077 1081
19. EJ Breese CA Michie SW Nicholls SH Murch CB Williams P Domizio JA Walker-Smith TT. McDonald Tumor necrosis factor α–producing cells in the intestinal mucosa of children with inflammatory bowel disease Gastroenterology 106 1994 1455 1466
20. SE Plevy CJ Landers J Prehn NM Carramanzana RL Deem D Shealy SR. Targan A role for TNF-α and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease J Immunol 159 1997 6276 6282
21. M Vajdy MH Kosco-Vilbois M Kopf G Köhler N. Lycke Impaired mucosal immune response in interleukin-4 targeted mice J Exp Med 181 1995 41 53
22. SP Colgan MB Resnick CA Parkos C Delph-Archer D McGuirck AE Bacarra PF Weller JL. Madara IL-4 directly modulates function of a model human intestinal epithelium J Immunol 153 1994 2122 2129
23. BA Vallance CM Hogaboam CL Addison J Gauldie SM. Collins Interleukin-4 gene transfer to the intestine causes inflammation and muscle dysfunction in the mouse (abstr) Gastroenterology 110 1996 A1034
24. P Desreumaux E Brandt L Gambiez D Emilie K Geboes O Klein N Ectors A Cortot M Capron JF. Colombel Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease Gastroenterology 113 1997 118 126